nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—ABCB1—Dactinomycin—muscle cancer	0.254	0.34	CbGbCtD
Nizatidine—ABCB1—Vincristine—muscle cancer	0.157	0.21	CbGbCtD
Nizatidine—ABCB1—Etoposide—muscle cancer	0.143	0.192	CbGbCtD
Nizatidine—ABCB1—Doxorubicin—muscle cancer	0.0978	0.131	CbGbCtD
Nizatidine—ABCB1—Methotrexate—muscle cancer	0.0948	0.127	CbGbCtD
Nizatidine—BCHE—diaphragm—muscle cancer	0.0177	0.512	CbGeAlD
Nizatidine—Hyperuricaemia—Vincristine—muscle cancer	0.0047	0.0215	CcSEcCtD
Nizatidine—Blood uric acid increased—Vincristine—muscle cancer	0.00444	0.0203	CcSEcCtD
Nizatidine—Hyperuricaemia—Etoposide—muscle cancer	0.00381	0.0174	CcSEcCtD
Nizatidine—Blood uric acid increased—Etoposide—muscle cancer	0.0036	0.0165	CcSEcCtD
Nizatidine—HRH2—cardiac atrium—muscle cancer	0.00321	0.0931	CbGeAlD
Nizatidine—Pneumonia—Dactinomycin—muscle cancer	0.00275	0.0126	CcSEcCtD
Nizatidine—Erectile dysfunction—Vincristine—muscle cancer	0.00252	0.0115	CcSEcCtD
Nizatidine—Pneumonia—Vincristine—muscle cancer	0.00245	0.0112	CcSEcCtD
Nizatidine—Hepatitis—Dactinomycin—muscle cancer	0.00245	0.0112	CcSEcCtD
Nizatidine—Pharyngitis—Dactinomycin—muscle cancer	0.00243	0.0111	CcSEcCtD
Nizatidine—HRH2—head—muscle cancer	0.0024	0.0696	CbGeAlD
Nizatidine—Amblyopia—Doxorubicin—muscle cancer	0.00237	0.0109	CcSEcCtD
Nizatidine—Sweating—Vincristine—muscle cancer	0.00234	0.0107	CcSEcCtD
Nizatidine—Hyperuricaemia—Methotrexate—muscle cancer	0.00228	0.0104	CcSEcCtD
Nizatidine—Hepatic enzyme increased—Methotrexate—muscle cancer	0.00224	0.0102	CcSEcCtD
Nizatidine—Bronchospasm—Etoposide—muscle cancer	0.00218	0.00997	CcSEcCtD
Nizatidine—Liver injury—Doxorubicin—muscle cancer	0.00218	0.00996	CcSEcCtD
Nizatidine—Vasculitis—Methotrexate—muscle cancer	0.00217	0.00991	CcSEcCtD
Nizatidine—Blood uric acid increased—Methotrexate—muscle cancer	0.00216	0.00985	CcSEcCtD
Nizatidine—Pneumonia—Etoposide—muscle cancer	0.00199	0.00909	CcSEcCtD
Nizatidine—Hyperuricaemia—Doxorubicin—muscle cancer	0.00198	0.00903	CcSEcCtD
Nizatidine—Anaemia—Dactinomycin—muscle cancer	0.00197	0.00902	CcSEcCtD
Nizatidine—Jaundice—Etoposide—muscle cancer	0.00193	0.00881	CcSEcCtD
Nizatidine—Gynaecomastia—Methotrexate—muscle cancer	0.00189	0.00866	CcSEcCtD
Nizatidine—Blood uric acid increased—Doxorubicin—muscle cancer	0.00187	0.00853	CcSEcCtD
Nizatidine—Back pain—Vincristine—muscle cancer	0.00184	0.00843	CcSEcCtD
Nizatidine—Hepatocellular injury—Doxorubicin—muscle cancer	0.00183	0.00838	CcSEcCtD
Nizatidine—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00183	0.00838	CcSEcCtD
Nizatidine—Myalgia—Dactinomycin—muscle cancer	0.00182	0.00831	CcSEcCtD
Nizatidine—Abnormal dreams—Doxorubicin—muscle cancer	0.00181	0.00828	CcSEcCtD
Nizatidine—Anaemia—Vincristine—muscle cancer	0.00176	0.00806	CcSEcCtD
Nizatidine—Infection—Dactinomycin—muscle cancer	0.00173	0.00791	CcSEcCtD
Nizatidine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00171	0.0078	CcSEcCtD
Nizatidine—Anorexia—Dactinomycin—muscle cancer	0.00166	0.00759	CcSEcCtD
Nizatidine—Convulsion—Vincristine—muscle cancer	0.00165	0.00755	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00163	0.00744	CcSEcCtD
Nizatidine—BCHE—smooth muscle tissue—muscle cancer	0.00163	0.0471	CbGeAlD
Nizatidine—Myalgia—Vincristine—muscle cancer	0.00162	0.00742	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00159	0.00726	CcSEcCtD
Nizatidine—Anaphylactic shock—Vincristine—muscle cancer	0.00156	0.00711	CcSEcCtD
Nizatidine—Infection—Vincristine—muscle cancer	0.00155	0.00707	CcSEcCtD
Nizatidine—Thrombocytopenia—Vincristine—muscle cancer	0.00152	0.00697	CcSEcCtD
Nizatidine—Decreased appetite—Dactinomycin—muscle cancer	0.00151	0.00692	CcSEcCtD
Nizatidine—Hyperhidrosis—Vincristine—muscle cancer	0.0015	0.00688	CcSEcCtD
Nizatidine—Back pain—Etoposide—muscle cancer	0.00149	0.00683	CcSEcCtD
Nizatidine—Pain—Dactinomycin—muscle cancer	0.00149	0.00681	CcSEcCtD
Nizatidine—Anorexia—Vincristine—muscle cancer	0.00148	0.00678	CcSEcCtD
Nizatidine—Irritability—Methotrexate—muscle cancer	0.00147	0.0067	CcSEcCtD
Nizatidine—Feeling abnormal—Dactinomycin—muscle cancer	0.00144	0.00656	CcSEcCtD
Nizatidine—Anaemia—Etoposide—muscle cancer	0.00143	0.00653	CcSEcCtD
Nizatidine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00142	0.00651	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00142	0.00648	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00141	0.00645	CcSEcCtD
Nizatidine—Insomnia—Vincristine—muscle cancer	0.00141	0.00644	CcSEcCtD
Nizatidine—BCHE—cardiac atrium—muscle cancer	0.0014	0.0406	CbGeAlD
Nizatidine—Body temperature increased—Dactinomycin—muscle cancer	0.00138	0.0063	CcSEcCtD
Nizatidine—Abdominal pain—Dactinomycin—muscle cancer	0.00138	0.0063	CcSEcCtD
Nizatidine—Decreased appetite—Vincristine—muscle cancer	0.00135	0.00618	CcSEcCtD
Nizatidine—Cough—Etoposide—muscle cancer	0.00135	0.00616	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00134	0.00614	CcSEcCtD
Nizatidine—Convulsion—Etoposide—muscle cancer	0.00134	0.00612	CcSEcCtD
Nizatidine—Pain—Vincristine—muscle cancer	0.00133	0.00608	CcSEcCtD
Nizatidine—Constipation—Vincristine—muscle cancer	0.00133	0.00608	CcSEcCtD
Nizatidine—Chest pain—Etoposide—muscle cancer	0.00132	0.00601	CcSEcCtD
Nizatidine—Eosinophilia—Methotrexate—muscle cancer	0.00132	0.00601	CcSEcCtD
Nizatidine—Gastrointestinal pain—Vincristine—muscle cancer	0.00127	0.00582	CcSEcCtD
Nizatidine—Confusional state—Etoposide—muscle cancer	0.00127	0.00581	CcSEcCtD
Nizatidine—Anaphylactic shock—Etoposide—muscle cancer	0.00126	0.00576	CcSEcCtD
Nizatidine—Infection—Etoposide—muscle cancer	0.00125	0.00573	CcSEcCtD
Nizatidine—Asthenia—Dactinomycin—muscle cancer	0.00125	0.00571	CcSEcCtD
Nizatidine—Thrombocytopenia—Etoposide—muscle cancer	0.00123	0.00564	CcSEcCtD
Nizatidine—Abdominal pain—Vincristine—muscle cancer	0.00123	0.00562	CcSEcCtD
Nizatidine—Body temperature increased—Vincristine—muscle cancer	0.00123	0.00562	CcSEcCtD
Nizatidine—Erectile dysfunction—Methotrexate—muscle cancer	0.00122	0.00559	CcSEcCtD
Nizatidine—Hyperhidrosis—Etoposide—muscle cancer	0.00122	0.00557	CcSEcCtD
Nizatidine—Anorexia—Etoposide—muscle cancer	0.0012	0.00549	CcSEcCtD
Nizatidine—Diarrhoea—Dactinomycin—muscle cancer	0.00119	0.00545	CcSEcCtD
Nizatidine—Pneumonia—Methotrexate—muscle cancer	0.00119	0.00544	CcSEcCtD
Nizatidine—Nasopharyngitis—Doxorubicin—muscle cancer	0.00119	0.00544	CcSEcCtD
Nizatidine—BCHE—bone marrow—muscle cancer	0.00118	0.0343	CbGeAlD
Nizatidine—Eosinophilia—Doxorubicin—muscle cancer	0.00114	0.0052	CcSEcCtD
Nizatidine—Sweating—Methotrexate—muscle cancer	0.00114	0.00519	CcSEcCtD
Nizatidine—BCHE—vagina—muscle cancer	0.00113	0.0328	CbGeAlD
Nizatidine—Somnolence—Etoposide—muscle cancer	0.00112	0.00512	CcSEcCtD
Nizatidine—Asthenia—Vincristine—muscle cancer	0.00112	0.0051	CcSEcCtD
Nizatidine—Vomiting—Dactinomycin—muscle cancer	0.00111	0.00506	CcSEcCtD
Nizatidine—Rash—Dactinomycin—muscle cancer	0.0011	0.00502	CcSEcCtD
Nizatidine—Decreased appetite—Etoposide—muscle cancer	0.0011	0.00501	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00109	0.00498	CcSEcCtD
Nizatidine—Constipation—Etoposide—muscle cancer	0.00108	0.00493	CcSEcCtD
Nizatidine—Pain—Etoposide—muscle cancer	0.00108	0.00493	CcSEcCtD
Nizatidine—Diarrhoea—Vincristine—muscle cancer	0.00107	0.00487	CcSEcCtD
Nizatidine—Hepatitis—Methotrexate—muscle cancer	0.00106	0.00486	CcSEcCtD
Nizatidine—Pharyngitis—Methotrexate—muscle cancer	0.00106	0.00482	CcSEcCtD
Nizatidine—BCHE—head—muscle cancer	0.00105	0.0303	CbGeAlD
Nizatidine—Feeling abnormal—Etoposide—muscle cancer	0.00104	0.00475	CcSEcCtD
Nizatidine—Nausea—Dactinomycin—muscle cancer	0.00103	0.00473	CcSEcCtD
Nizatidine—Pneumonia—Doxorubicin—muscle cancer	0.00103	0.00471	CcSEcCtD
Nizatidine—Gastrointestinal pain—Etoposide—muscle cancer	0.00103	0.00471	CcSEcCtD
Nizatidine—Dizziness—Vincristine—muscle cancer	0.00103	0.0047	CcSEcCtD
Nizatidine—BCHE—testis—muscle cancer	0.00101	0.0293	CbGeAlD
Nizatidine—Urticaria—Etoposide—muscle cancer	0.001	0.00458	CcSEcCtD
Nizatidine—Jaundice—Doxorubicin—muscle cancer	0.001	0.00457	CcSEcCtD
Nizatidine—Body temperature increased—Etoposide—muscle cancer	0.000997	0.00456	CcSEcCtD
Nizatidine—Abdominal pain—Etoposide—muscle cancer	0.000997	0.00456	CcSEcCtD
Nizatidine—Vomiting—Vincristine—muscle cancer	0.00099	0.00452	CcSEcCtD
Nizatidine—ABCB1—embryo—muscle cancer	0.000985	0.0285	CbGeAlD
Nizatidine—Sweating—Doxorubicin—muscle cancer	0.000983	0.00449	CcSEcCtD
Nizatidine—Rash—Vincristine—muscle cancer	0.000982	0.00449	CcSEcCtD
Nizatidine—Dermatitis—Vincristine—muscle cancer	0.000981	0.00448	CcSEcCtD
Nizatidine—Headache—Vincristine—muscle cancer	0.000975	0.00446	CcSEcCtD
Nizatidine—Sinusitis—Doxorubicin—muscle cancer	0.000962	0.0044	CcSEcCtD
Nizatidine—Nausea—Vincristine—muscle cancer	0.000925	0.00423	CcSEcCtD
Nizatidine—Rhinitis—Doxorubicin—muscle cancer	0.000923	0.00422	CcSEcCtD
Nizatidine—Hepatitis—Doxorubicin—muscle cancer	0.000921	0.00421	CcSEcCtD
Nizatidine—Pharyngitis—Doxorubicin—muscle cancer	0.000914	0.00418	CcSEcCtD
Nizatidine—Asthenia—Etoposide—muscle cancer	0.000905	0.00414	CcSEcCtD
Nizatidine—Back pain—Methotrexate—muscle cancer	0.000895	0.00409	CcSEcCtD
Nizatidine—Pruritus—Etoposide—muscle cancer	0.000892	0.00408	CcSEcCtD
Nizatidine—Diarrhoea—Etoposide—muscle cancer	0.000863	0.00394	CcSEcCtD
Nizatidine—Anaemia—Methotrexate—muscle cancer	0.000855	0.00391	CcSEcCtD
Nizatidine—Dizziness—Etoposide—muscle cancer	0.000834	0.00381	CcSEcCtD
Nizatidine—Cough—Methotrexate—muscle cancer	0.000808	0.00369	CcSEcCtD
Nizatidine—Convulsion—Methotrexate—muscle cancer	0.000802	0.00367	CcSEcCtD
Nizatidine—Vomiting—Etoposide—muscle cancer	0.000802	0.00366	CcSEcCtD
Nizatidine—Rash—Etoposide—muscle cancer	0.000795	0.00363	CcSEcCtD
Nizatidine—Dermatitis—Etoposide—muscle cancer	0.000794	0.00363	CcSEcCtD
Nizatidine—Headache—Etoposide—muscle cancer	0.00079	0.00361	CcSEcCtD
Nizatidine—Flatulence—Doxorubicin—muscle cancer	0.00079	0.00361	CcSEcCtD
Nizatidine—Chest pain—Methotrexate—muscle cancer	0.000788	0.0036	CcSEcCtD
Nizatidine—Myalgia—Methotrexate—muscle cancer	0.000788	0.0036	CcSEcCtD
Nizatidine—Tension—Doxorubicin—muscle cancer	0.000786	0.00359	CcSEcCtD
Nizatidine—Nervousness—Doxorubicin—muscle cancer	0.000778	0.00356	CcSEcCtD
Nizatidine—Back pain—Doxorubicin—muscle cancer	0.000775	0.00354	CcSEcCtD
Nizatidine—Confusional state—Methotrexate—muscle cancer	0.000762	0.00348	CcSEcCtD
Nizatidine—Anaphylactic shock—Methotrexate—muscle cancer	0.000755	0.00345	CcSEcCtD
Nizatidine—Infection—Methotrexate—muscle cancer	0.00075	0.00343	CcSEcCtD
Nizatidine—Nausea—Etoposide—muscle cancer	0.000749	0.00342	CcSEcCtD
Nizatidine—ABCB1—renal system—muscle cancer	0.000746	0.0216	CbGeAlD
Nizatidine—Anaemia—Doxorubicin—muscle cancer	0.000741	0.00339	CcSEcCtD
Nizatidine—Thrombocytopenia—Methotrexate—muscle cancer	0.00074	0.00338	CcSEcCtD
Nizatidine—Hyperhidrosis—Methotrexate—muscle cancer	0.00073	0.00334	CcSEcCtD
Nizatidine—Anorexia—Methotrexate—muscle cancer	0.00072	0.00329	CcSEcCtD
Nizatidine—Cough—Doxorubicin—muscle cancer	0.000699	0.0032	CcSEcCtD
Nizatidine—Convulsion—Doxorubicin—muscle cancer	0.000694	0.00317	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000688	0.00315	CcSEcCtD
Nizatidine—Insomnia—Methotrexate—muscle cancer	0.000683	0.00312	CcSEcCtD
Nizatidine—Myalgia—Doxorubicin—muscle cancer	0.000682	0.00312	CcSEcCtD
Nizatidine—Chest pain—Doxorubicin—muscle cancer	0.000682	0.00312	CcSEcCtD
Nizatidine—Anxiety—Doxorubicin—muscle cancer	0.00068	0.00311	CcSEcCtD
Nizatidine—Somnolence—Methotrexate—muscle cancer	0.000671	0.00307	CcSEcCtD
Nizatidine—Dry mouth—Doxorubicin—muscle cancer	0.000667	0.00305	CcSEcCtD
Nizatidine—Dyspepsia—Methotrexate—muscle cancer	0.000665	0.00304	CcSEcCtD
Nizatidine—Confusional state—Doxorubicin—muscle cancer	0.000659	0.00301	CcSEcCtD
Nizatidine—Decreased appetite—Methotrexate—muscle cancer	0.000657	0.003	CcSEcCtD
Nizatidine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000654	0.00299	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000652	0.00298	CcSEcCtD
Nizatidine—Infection—Doxorubicin—muscle cancer	0.00065	0.00297	CcSEcCtD
Nizatidine—Pain—Methotrexate—muscle cancer	0.000646	0.00295	CcSEcCtD
Nizatidine—Thrombocytopenia—Doxorubicin—muscle cancer	0.00064	0.00293	CcSEcCtD
Nizatidine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000632	0.00289	CcSEcCtD
Nizatidine—Anorexia—Doxorubicin—muscle cancer	0.000623	0.00285	CcSEcCtD
Nizatidine—Feeling abnormal—Methotrexate—muscle cancer	0.000622	0.00284	CcSEcCtD
Nizatidine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000618	0.00282	CcSEcCtD
Nizatidine—Urticaria—Methotrexate—muscle cancer	0.0006	0.00274	CcSEcCtD
Nizatidine—Abdominal pain—Methotrexate—muscle cancer	0.000597	0.00273	CcSEcCtD
Nizatidine—Body temperature increased—Methotrexate—muscle cancer	0.000597	0.00273	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000596	0.00272	CcSEcCtD
Nizatidine—Insomnia—Doxorubicin—muscle cancer	0.000592	0.0027	CcSEcCtD
Nizatidine—Somnolence—Doxorubicin—muscle cancer	0.000581	0.00266	CcSEcCtD
Nizatidine—Dyspepsia—Doxorubicin—muscle cancer	0.000576	0.00263	CcSEcCtD
Nizatidine—Decreased appetite—Doxorubicin—muscle cancer	0.000569	0.0026	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000565	0.00258	CcSEcCtD
Nizatidine—ABCB1—bone marrow—muscle cancer	0.000564	0.0163	CbGeAlD
Nizatidine—Pain—Doxorubicin—muscle cancer	0.000559	0.00256	CcSEcCtD
Nizatidine—Constipation—Doxorubicin—muscle cancer	0.000559	0.00256	CcSEcCtD
Nizatidine—Asthenia—Methotrexate—muscle cancer	0.000542	0.00248	CcSEcCtD
Nizatidine—ABCB1—vagina—muscle cancer	0.00054	0.0156	CbGeAlD
Nizatidine—Feeling abnormal—Doxorubicin—muscle cancer	0.000539	0.00246	CcSEcCtD
Nizatidine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000535	0.00244	CcSEcCtD
Nizatidine—Pruritus—Methotrexate—muscle cancer	0.000534	0.00244	CcSEcCtD
Nizatidine—Urticaria—Doxorubicin—muscle cancer	0.00052	0.00237	CcSEcCtD
Nizatidine—Abdominal pain—Doxorubicin—muscle cancer	0.000517	0.00236	CcSEcCtD
Nizatidine—Body temperature increased—Doxorubicin—muscle cancer	0.000517	0.00236	CcSEcCtD
Nizatidine—Diarrhoea—Methotrexate—muscle cancer	0.000517	0.00236	CcSEcCtD
Nizatidine—Dizziness—Methotrexate—muscle cancer	0.000499	0.00228	CcSEcCtD
Nizatidine—ABCB1—head—muscle cancer	0.000499	0.0145	CbGeAlD
Nizatidine—ABCB1—testis—muscle cancer	0.000482	0.014	CbGeAlD
Nizatidine—Vomiting—Methotrexate—muscle cancer	0.00048	0.0022	CcSEcCtD
Nizatidine—Rash—Methotrexate—muscle cancer	0.000476	0.00218	CcSEcCtD
Nizatidine—Dermatitis—Methotrexate—muscle cancer	0.000476	0.00217	CcSEcCtD
Nizatidine—Headache—Methotrexate—muscle cancer	0.000473	0.00216	CcSEcCtD
Nizatidine—Asthenia—Doxorubicin—muscle cancer	0.000469	0.00214	CcSEcCtD
Nizatidine—Pruritus—Doxorubicin—muscle cancer	0.000463	0.00211	CcSEcCtD
Nizatidine—Nausea—Methotrexate—muscle cancer	0.000449	0.00205	CcSEcCtD
Nizatidine—Diarrhoea—Doxorubicin—muscle cancer	0.000447	0.00205	CcSEcCtD
Nizatidine—Dizziness—Doxorubicin—muscle cancer	0.000432	0.00198	CcSEcCtD
Nizatidine—Vomiting—Doxorubicin—muscle cancer	0.000416	0.0019	CcSEcCtD
Nizatidine—Rash—Doxorubicin—muscle cancer	0.000412	0.00188	CcSEcCtD
Nizatidine—Dermatitis—Doxorubicin—muscle cancer	0.000412	0.00188	CcSEcCtD
Nizatidine—Headache—Doxorubicin—muscle cancer	0.00041	0.00187	CcSEcCtD
Nizatidine—Nausea—Doxorubicin—muscle cancer	0.000388	0.00178	CcSEcCtD
